Trial Title:
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT ID:
NCT06097728
Condition:
Unresectable Pleural Mesothelioma
Conditions: Official terms:
Mesothelioma
Mesothelioma, Malignant
Carboplatin
Nivolumab
Pemetrexed
Ipilimumab
Conditions: Keywords:
Mesothelioma
Pleural Mesothelioma
Unresectable Pleural Mesothelioma
Advanced pleural mesothelioma
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
This is a randomized, open-label, Phase III trial in participants with untreated
unresectable pleural mesothelioma. Approximately 600 participants across histology
subtypes will be randomized in a 1:1 ratio to receive volrustomig in combination with
carboplatin plus pemetrexed or the investigator's choice of nivolumab plus ipilimumab or
platinum plus pemetrexed chemotherapy for participants with epithelioid histology, and
nivolumab plus ipilumab for participants with non-epithelioid histology.
Primary purpose:
Treatment
Masking:
Single (Outcomes Assessor)
Masking description:
This is an open-label study for the personnel at study sites; the specific treatment to
be taken by a participant will be assigned using an Interactive Response
Technology/Randomization and Trial Supply Management. To maintain the integrity of the
study, AstraZeneca personnel directly involved in the study conduct will not undertake or
have access to efficacy data aggregated by treatment arm prior to final data readout for
the primary endpoint.
Intervention:
Intervention type:
Drug
Intervention name:
Volrustomig
Description:
MEDI5752: Administered as IV infusion
Arm group label:
Volrustomig + Carboplatin + pemetrexed
Other name:
MEDI5752
Intervention type:
Drug
Intervention name:
Pemetrexed
Description:
Alimta: Administered as IV infusion
Arm group label:
Investigator's choice of standard care
Arm group label:
Volrustomig + Carboplatin + pemetrexed
Other name:
Alimta
Intervention type:
Drug
Intervention name:
Carboplatin
Description:
Paraplatin: Administered as IV infusion
Arm group label:
Investigator's choice of standard care
Arm group label:
Volrustomig + Carboplatin + pemetrexed
Other name:
Paraplatin
Intervention type:
Drug
Intervention name:
Cisplatin
Description:
Platinol: Administered as IV infusion
Arm group label:
Investigator's choice of standard care
Other name:
Platinol
Intervention type:
Drug
Intervention name:
Nivolumab
Description:
Opdivo: Administered as IV infusion
Arm group label:
Investigator's choice of standard care
Other name:
Opdivo
Intervention type:
Drug
Intervention name:
Ipilimumab
Description:
Yervoy: Administered as IV infusion
Arm group label:
Investigator's choice of standard care
Other name:
Yervoy
Summary:
This is a phase III, randomized, open-label, multicenter, global study to determine the
efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the
investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants
with unresectable pleural mesothelioma.
Detailed description:
Adult patients with histologically proven diagnosis of pleural mesothelioma with advanced
unresectable disease are eligible to be enrolled. Patients will be randomized 1:1 to
receive Volrustomig (MEDI5752) + Carboplatin + Pemetrexed or the investigator's choice of
platinum+Pemetrexed or Nivolumab+Ipilimumab, based on their histology.
Criteria for eligibility:
Criteria:
Key Inclusion Criteria:
- Participant must be ≥ 18 years at the time of screening
- Histologically proven diagnosis of pleural mesothelioma with known histology
(epithelioid vs. non-epithelioid)
- Advanced unresectable disease that cannot be treated with curative surgery (with or
without chemotherapy)
- WHO/ECOG performance status of 0 or 1 with no deterioration (that is, ECOG PS>1)
over the previous 2 weeks prior to day of first dosing
- Has measurable disease per modified RECIST1.1
- Has adequate bone marrow reserve and organ function at baseline
Key Exclusion Criteria:
- As judged by the investigator, any condition that would interfere with evaluation of
the investigational product or interpretation of participant safety or study
results.
- Active or prior documented autoimmune or inflammatory disorders
- History of another primary malignancy with exceptions.
- Uncontrolled intercurrent illness
- Tuberculosis, hepatitis B (HBV) or hepatitis C (HCV), human immunodeficiency virus
(HIV) infection that is not well controlled
- Any concurrent chemotherapy, radiotherapy, investigational, biologic, or hormonal
therapy for cancer treatment
- Untreated or progressive CNS metastatic disease
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Research Site
Address:
City:
Phoenix
Zip:
85054
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Duarte
Zip:
91010
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Santa Rosa
Zip:
95403
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Aurora
Zip:
80045
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Jacksonville
Zip:
32224
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Atlanta
Zip:
30322
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Chicago
Zip:
60637
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Baltimore
Zip:
21231
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Rochester
Zip:
55905
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
East Brunswick
Zip:
08816
Country:
United States
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Commack
Zip:
11725
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Valhalla
Zip:
10595
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Cleveland
Zip:
44111
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Cleveland
Zip:
44124
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Cleveland
Zip:
44195
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Columbus
Zip:
43210
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Independence
Zip:
44131
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Portland
Zip:
97213
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Portland
Zip:
97239
Country:
United States
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Philadelphia
Zip:
19104
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Fairfax
Zip:
22031
Country:
United States
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Chermside
Zip:
4032
Country:
Australia
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Clayton
Zip:
3168
Country:
Australia
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Melbourne
Zip:
3000
Country:
Australia
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Nedlands
Zip:
6009
Country:
Australia
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Westmead
Zip:
2145
Country:
Australia
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Anderlecht
Zip:
1070
Country:
Belgium
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Antwerpen
Zip:
2020
Country:
Belgium
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Gent
Zip:
9000
Country:
Belgium
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hasselt
Zip:
3500
Country:
Belgium
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Leuven
Zip:
3000
Country:
Belgium
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Sint-Niklaas
Zip:
9100
Country:
Belgium
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Barretos
Zip:
14784-400
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Fortaleza
Zip:
60336-045
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Joao Pessoa
Zip:
58013-140
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Porto Alegre
Zip:
91350-200
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rio de Janeiro
Zip:
22281-100
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Santo Andre
Zip:
09060-650
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
São Paulo
Zip:
01246-000
Country:
Brazil
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Edmonton
Zip:
T6G 1Z2
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hamilton
Zip:
L8V 1C3
Country:
Canada
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
London
Zip:
N6A 5W9
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ottawa
Zip:
K1H 8L6
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Toronto
Zip:
M5G 1X6
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Montreal
Zip:
H2X 0C1
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Quebec
Zip:
G1V 4G5
Country:
Canada
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Beijing
Zip:
100142
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Beijing
Zip:
100210
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Changsha
Zip:
410013
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Chengdu
Zip:
610042
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Guangzhou
Zip:
510060
Country:
China
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Guangzhou
Zip:
510180
Country:
China
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Hangzhou
Zip:
310022
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Harbin
Zip:
150049
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Kunming
Zip:
650118
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Lanzhou
Zip:
730000
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Nanchang
Zip:
330006
Country:
China
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Ningbo
Zip:
315100
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shanghai
Zip:
200032
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Shenyang
Zip:
110044
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Taiyuan
Zip:
030000
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Taiyuan
Zip:
030032
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Tianjin
Zip:
300052
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Tianjin
Zip:
300060
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Wuhan
Zip:
430030
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Xi'an
Zip:
710061
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Zhengzhou
Zip:
450008
Country:
China
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Aarhus N
Zip:
8200
Country:
Denmark
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Copenhagen
Zip:
2100
Country:
Denmark
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Brest
Zip:
29200
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Creteil Cedex
Zip:
94010
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Le Mans Cedex
Zip:
72037
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lille
Zip:
59037
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lyon
Zip:
69373
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Marseille Cedex 20
Zip:
13015
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Montpellier
Zip:
34298
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Paris
Zip:
75877
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rouen
Zip:
76031
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Saint Herblain
Zip:
44800
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Strasbourg
Zip:
67091
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Toulouse
Zip:
31059
Country:
France
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Berlin
Zip:
13125
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Berlin
Zip:
14109
Country:
Germany
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Bochum
Zip:
44791
Country:
Germany
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Essen
Zip:
45130
Country:
Germany
Status:
Suspended
Facility:
Name:
Research Site
Address:
City:
Gauting
Zip:
82131
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Georgsmarienhuette
Zip:
49124
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hamburg
Zip:
21075
Country:
Germany
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Heidelberg
Zip:
69126
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kiel
Zip:
24105
Country:
Germany
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Köln
Zip:
51109
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Muenster
Zip:
48153
Country:
Germany
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Alessandria
Zip:
15100
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Bari
Zip:
70124
Country:
Italy
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Bergamo
Zip:
24125
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Milan
Zip:
20141
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Monza
Zip:
20052
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Orbassano
Zip:
10043
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Padova
Zip:
35128
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Parma
Zip:
43100
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rozzano
Zip:
20089
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Varese
Zip:
21100
Country:
Italy
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Amagasaki-shi
Zip:
660-8550
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Hiroshima-shi
Zip:
734-8551
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kitakyushu-shi
Zip:
807-8555
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Matsuyama-shi
Zip:
791-0280
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nagoya-shi
Zip:
466-8560
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Nishinomiya-shi
Zip:
663-8501
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Okayama-shi
Zip:
702-8055
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Osakasayama-shi
Zip:
589-8511
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Tokyo
Zip:
104-0045
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ube-shi
Zip:
755-0241
Country:
Japan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Cheongju-si
Zip:
28644
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
03080
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
06351
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Seoul
Zip:
06591
Country:
Korea, Republic of
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Amsterdam
Zip:
1066CX
Country:
Netherlands
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Eindhoven
Zip:
5623EJ
Country:
Netherlands
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rotterdam
Zip:
3015 GD
Country:
Netherlands
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Lørenskog
Zip:
1478
Country:
Norway
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Oslo
Zip:
450
Country:
Norway
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Bydgoszcz
Zip:
85-796
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Bystra
Zip:
43-360
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Olsztyn
Zip:
10-357
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Poznań
Zip:
60-569
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Rzeszów
Zip:
35-241
Country:
Poland
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Warszawa
Zip:
02-781
Country:
Poland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Amanzimtoti
Zip:
4126
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Johannesburg
Zip:
2013
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kraaifontein
Zip:
7570
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Parktown
Zip:
2193
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Pretoria
Zip:
0002
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Pretoria
Zip:
0081
Country:
South Africa
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Barakaldo
Zip:
48903
Country:
Spain
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Barcelona
Zip:
8035
Country:
Spain
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Madrid
Zip:
28041
Country:
Spain
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Oviedo
Zip:
33011
Country:
Spain
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Baden
Zip:
CH-5405
Country:
Switzerland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Basel
Zip:
4031
Country:
Switzerland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Bern
Zip:
3010
Country:
Switzerland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Fribourg
Zip:
1700
Country:
Switzerland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
St. Gallen
Zip:
9007
Country:
Switzerland
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Kaohsiung
Zip:
80756
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taichung
Zip:
40705
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Tainan City
Zip:
70403
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taipei
Zip:
10002
Country:
Taiwan
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Adana
Zip:
01060
Country:
Turkey
Status:
Withdrawn
Facility:
Name:
Research Site
Address:
City:
Ankara
Zip:
06280
Country:
Turkey
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Ankara
Zip:
06800
Country:
Turkey
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Diyarbakir
Zip:
21280
Country:
Turkey
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Izmir
Zip:
35110
Country:
Turkey
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Cambridge
Zip:
CB20QQ
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Cardiff, Wales
Zip:
CF5 6NF
Country:
United Kingdom
Status:
Not yet recruiting
Facility:
Name:
Research Site
Address:
City:
Leeds
Zip:
LS9 7TF
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Leicester
Zip:
LE1 5WW
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
London
Zip:
NW1 2PG
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
London
Zip:
SE1 9RT
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
London
Zip:
SW3 6JJ
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Manchester
Zip:
M23 9LT
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Middlesborough
Zip:
TS4 3BW
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Newcastle-upon-Tyne
Zip:
NE2 4HH
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Portsmouth
Zip:
PO6 3LY
Country:
United Kingdom
Status:
Recruiting
Facility:
Name:
Research Site
Address:
City:
Taunton
Zip:
TA1 5DA
Country:
United Kingdom
Status:
Recruiting
Start date:
November 9, 2023
Completion date:
March 13, 2028
Lead sponsor:
Agency:
AstraZeneca
Agency class:
Industry
Source:
AstraZeneca
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06097728
